What adjustments should be made to the NPH dose and carb ratio, and what sliding scale regimen is recommended for a patient with hyperglycemia on prednisone and NPH insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Steroid-Induced Hyperglycemia with NPH Insulin

For a patient with blood glucose of 306 mg/dL on prednisone 60 mg with current NPH dose of 10 units and carb ratio of 1:15, the NPH dose should be increased to 30 units daily (0.3 units/kg) and the carb ratio should be adjusted to 1:10, with a sliding scale of 1 unit for every 50 mg/dL above 150 mg/dL. 1

NPH Insulin Adjustment

  • For steroid-induced hyperglycemia, NPH insulin is the preferred insulin formulation due to its intermediate-acting profile that peaks at 4-6 hours, aligning with the peak hyperglycemic effect of glucocorticoids 1
  • The current dose of 10 units is insufficient for a 97.8 kg patient on high-dose prednisone (60 mg) 1
  • Initial NPH insulin dosing should be 0.3 units/kg per day for patients on high-dose glucocorticoids, which for a patient weighing 97.8 kg equals approximately 30 units 1, 2
  • Morning administration of NPH insulin is specifically recommended to match the pharmacokinetic profile of daily glucocorticoid therapy 1

Carbohydrate Ratio Adjustment

  • The current carb ratio of 1:15 is too conservative for a patient with significant steroid-induced hyperglycemia 1
  • Adjust the carbohydrate ratio from 1:15 to 1:10 to provide more insulin coverage for meals 2
  • This adjustment accounts for the insulin resistance caused by high-dose prednisone therapy 2

Recommended Sliding Scale

  • Implement a sliding scale starting at 150 mg/dL 2, 1:
    • 150-200 mg/dL: add 1 unit
    • 201-250 mg/dL: add 2 units
    • 251-300 mg/dL: add 3 units
    • 301-350 mg/dL: add 4 units
    • 350 mg/dL: add 5 units and contact provider 2

Monitoring and Further Adjustments

  • Monitor blood glucose before meals and at bedtime to assess the adequacy of the NPH dose and carb ratio 1
  • If hypoglycemia occurs, determine the cause; if no clear reason is found, lower the NPH dose by 10-20% 2, 3
  • For persistent hyperglycemia, consider increasing the NPH dose by 2 units every 3 days until target blood glucose is achieved 2
  • Consider splitting the NPH dose (2/3 morning, 1/3 evening) if daytime hyperglycemia persists despite dose adjustments 1, 2

Special Considerations for This Patient

  • With a BMI of 31, this patient likely has baseline insulin resistance, requiring higher insulin doses 1
  • The current NPH dose of 10 units (approximately 0.1 units/kg) is at the lowest end of the recommended starting range and insufficient for steroid-induced hyperglycemia 2, 1
  • Research shows that patients on high-dose glucocorticoids may require 40-60% more insulin than standard dosing 1, 4
  • NPH insulin has been shown to be more effective than glargine for steroid-induced hyperglycemia, with potentially lower total daily insulin requirements 4

Common Pitfalls to Avoid

  • Avoid bedtime NPH in patients with steroid-induced hyperglycemia as the peak action may cause nocturnal hypoglycemia 1, 3
  • Do not underestimate insulin requirements in patients on high-dose steroids; inadequate dosing leads to persistent hyperglycemia 2, 1
  • Be aware that insulin requirements will change if the prednisone dose is tapered; plan to reduce NPH by 10-20% with steroid dose reductions 1
  • Consider prescription of glucagon for emergent hypoglycemia, particularly important during insulin dose adjustments 2, 3

References

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A retrospective study comparing neutral protamine hagedorn insulin with glargine as basal therapy in prednisone-associated diabetes mellitus in hospitalized patients.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.